Levi & Korsinsky Investigates Potential Securities Fraud by Rentokil Initial plc (RTO)
Rentokil Initial plc is currently under investigation for possible violations of federal securities laws. The company disclosed on September 11, 2024, that it anticipates a full-year adjusted pretax profit of about £700 million, down from £766 million the previous year. This decline is attributed to weaker-than-expected sales in North America, Rentokil’s largest market. To address cost overruns, the company also announced plans to reduce an undisclosed number of jobs in its U.S. workforce.
As a result of this news, Rentokil’s American depositary receipt (“ADR”) price dropped by over 21% on September 11, 2024. Investors seeking more information can visit the following link: [link to the submission form for Rentokil Initial plc lawsuit]. For direct inquiries, Joseph E. Levi, Esq. can be reached via email at [email protected] or by phone at (212)363-7500.
Levi & Korsinsky LLP, the firm investigating this matter, has a strong reputation for handling securities litigation cases. With over 20 years of experience, they have successfully secured significant compensation for shareholders and have a proven track record of winning high-stakes cases. Their team of more than 70 employees is dedicated to representing investors in complex securities litigation issues. Levi & Korsinsky has been consistently recognized as one of the top securities litigation firms in the United States by ISS Securities Class Action Services’ Top 50 Report for seven consecutive years.
It’s important to note that past results do not guarantee similar outcomes in the future. For any further inquiries, Levi & Korsinsky LLP can be contacted at the following address: 33 Whitehall Street, 17th Floor, New York, NY 10004. Telephone: (212)363-7500. Fax: (212)363-7171. More information about Levi & Korsinsky can be found on their website.
